These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9628433)
21. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases. Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867 [TBL] [Abstract][Full Text] [Related]
22. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia]. Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405 [TBL] [Abstract][Full Text] [Related]
23. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens. Al Gwaiz LA; Bassioni W Histol Histopathol; 2008 Oct; 23(10):1223-8. PubMed ID: 18712674 [TBL] [Abstract][Full Text] [Related]
25. Immunophenotype of normal and leukemic bone marrow B-precursors in a Brazilian population. A comparative analysis by quantitative fluorescence cytometry. Rego EM; Garcia AB; Carneiro JJ; Falcão RP Braz J Med Biol Res; 2001 Feb; 34(2):183-94. PubMed ID: 11175493 [TBL] [Abstract][Full Text] [Related]
26. B-cell precursor bone marrow reconstitution after bone marrow transplantation. Leitenberg D; Rappeport JM; Smith BR Am J Clin Pathol; 1994 Aug; 102(2):231-6. PubMed ID: 8042594 [TBL] [Abstract][Full Text] [Related]
27. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia]. Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409 [TBL] [Abstract][Full Text] [Related]
28. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Syrjälä M; Anttila VJ; Ruutu T; Jansson SE Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295 [TBL] [Abstract][Full Text] [Related]
29. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up. Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637 [TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623 [TBL] [Abstract][Full Text] [Related]
31. Elevated common acute lymphoblastic leukemia antigen expression in pediatric immune thrombocytopenic purpura. Cornelius AS; Campbell D; Schwartz E; Poncz M Am J Pediatr Hematol Oncol; 1991; 13(1):57-61. PubMed ID: 1827572 [TBL] [Abstract][Full Text] [Related]
32. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Drach J; Drach D; Glassl H; Gattringer C; Huber H Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006 [TBL] [Abstract][Full Text] [Related]
33. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia. Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697 [TBL] [Abstract][Full Text] [Related]
34. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024 [TBL] [Abstract][Full Text] [Related]
35. Immunophenotyping pediatric leukemias in Kelantan, Malaysia. Menon BS; Dasgupta A; Jackson N Pediatr Hematol Oncol; 1998; 15(2):175-8. PubMed ID: 9592844 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126 [TBL] [Abstract][Full Text] [Related]
37. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Baryshnikov AYu ; Polosukhina ER; Tupitsin NN; Gavrikova NV; Andreeva LYu ; Zabotina TN; Mayakova SA; Kurmashov VI; Syrkin AB; Kadagidze ZG; Blochin DYu ; Shishkin YuV Adv Exp Med Biol; 1999; 457():251-8. PubMed ID: 10500800 [TBL] [Abstract][Full Text] [Related]
38. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping. Hanson CA; Ross CW; Schnitzer B Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985 [TBL] [Abstract][Full Text] [Related]
39. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study. Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947 [TBL] [Abstract][Full Text] [Related]